These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30507294)

  • 41. Accessibility of opioid analgesics and barriers to optimal chronic pain treatment in Poland in 2000-2015.
    Dzierżanowski T; Ciałkowska-Rysz A
    Support Care Cancer; 2017 Mar; 25(3):775-781. PubMed ID: 27771783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should Physicians Recommend Replacing Opioids With Cannabis?
    Humphreys K; Saitz R
    JAMA; 2019 Feb; 321(7):639-640. PubMed ID: 30707218
    [No Abstract]   [Full Text] [Related]  

  • 43. Opioid therapy in chronic pain.
    Ballantyne JC
    Phys Med Rehabil Clin N Am; 2015 May; 26(2):201-18. PubMed ID: 25952061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of buprenorphine transdermal system in the management of pain in older adults.
    Pergolizzi JV; Raffa RB; Marcum Z; Colucci S; Ripa SR
    Postgrad Med; 2017 Jan; 129(1):92-101. PubMed ID: 27929709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment strategies to overcome end-of-dose failure with oral and transdermal opioids.
    Hall LM; O'Lenic K
    J Pharm Pract; 2012 Oct; 25(5):503-9. PubMed ID: 23011962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.
    Coplan PM; Sessler NE; Harikrishnan V; Singh R; Perkel C
    Postgrad Med; 2017 Jan; 129(1):55-61. PubMed ID: 27922764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid Management in Older Adults with Chronic Kidney Disease: A Review.
    Owsiany MT; Hawley CE; Triantafylidis LK; Paik JM
    Am J Med; 2019 Dec; 132(12):1386-1393. PubMed ID: 31295441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain.
    Wilder CM; Miller SC; Tiffany E; Winhusen T; Winstanley EL; Stein MD
    J Addict Dis; 2016; 35(1):42-51. PubMed ID: 26566771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal buprenorphine, opioid rotation to sublingual buprenorphine, and the avoidance of precipitated withdrawal: a review of the literature and demonstration in three chronic pain patients treated with butrans.
    Kornfeld H; Reetz H
    Am J Ther; 2015; 22(3):199-205. PubMed ID: 23846520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buprenorphine for neuropathic pain--targeting hyperalgesia.
    Induru RR; Davis MP
    Am J Hosp Palliat Care; 2009 Dec-2010 Jan; 26(6):470-3. PubMed ID: 19666890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of Challenging Pharmacologic Issues in Chronic Pain and Substance Abuse Disorders.
    Cornett EM; Budish R; Latimer D; Hart B; Urman RD; Kaye AD
    Anesthesiol Clin; 2018 Dec; 36(4):615-626. PubMed ID: 30390782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Buprenorphine in cancer pain.
    Davis MP
    Support Care Cancer; 2005 Nov; 13(11):878-87. PubMed ID: 16010532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.
    Lundorff L; Sjøgren P; Hansen OB; Jonsson T; Nielsen PR; Christrup L
    J Opioid Manag; 2013; 9(4):255-62. PubMed ID: 24353018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safe and appropriate opioid use.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):2-3. PubMed ID: 23527665
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study.
    Serpell M; Tripathi S; Scherzinger S; Rojas-Farreras S; Oksche A; Wilson M
    Patient; 2016 Feb; 9(1):35-46. PubMed ID: 26547914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.
    Pade PA; Cardon KE; Hoffman RM; Geppert CM
    J Subst Abuse Treat; 2012 Dec; 43(4):446-50. PubMed ID: 22980449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comprehensive review of partial opioid agonists for the treatment of chronic pain.
    Gress K; Charipova K; Jung JW; Kaye AD; Paladini A; Varrassi G; Viswanath O; Urits I
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):449-461. PubMed ID: 33004158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous Perioperative Sublingual Buprenorphine.
    Silva MJ; Rubinstein A
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):289-293. PubMed ID: 27736284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients.
    Canneti A; Luzi M; Di Marco P; Cannata F; Pasqualitto F; Spinoglio A; Reale C
    Minerva Anestesiol; 2013 Aug; 79(8):871-83. PubMed ID: 23558760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.